A case of treatment for pulmonary infection caused by multidrug-resistant Acinetobacter baumannii.

IF 0.8 Q4 RESPIRATORY SYSTEM

Respirology Case Reports Pub Date : 2024-07-01 DOI:10.1002/rcr2.1420

Chenxia Guo, Shaohua Xu, Wei Yan

引用次数: 0

Abstract

Acinetobacter baumannii is a major pathogen in hospital-acquired infections notorious for its strong acquired resistance and complex drug resistance mechanisms. Owing to the lack of effective drugs, the mortality rate of extensively drug-resistant A. baumannii pneumonia can reach as high as 65%. This article analyzes a case where a combination of cefoperazone-sulbactam, polymyxin B, and minocycline with rifampicin successfully treated XDR-AB pulmonary infection. Combination therapy is effective and has a particular clinical value.

查看原文本刊更多论文

一例耐多药鲍曼不动杆菌引起的肺部感染治疗病例。

鲍曼不动杆菌（Acinetobacter baumannii）是医院获得性感染的主要病原体，因其强大的获得性抗药性和复杂的耐药机制而臭名昭著。由于缺乏有效药物，广泛耐药鲍曼不动杆菌肺炎的死亡率高达 65%。本文分析了一例头孢哌酮-舒巴坦、多粘菌素B和米诺环素联合利福平成功治疗XDR-AB肺部感染的病例。联合疗法效果显著，具有特殊的临床价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Respirology Case Reports RESPIRATORY SYSTEM-

CiteScore

1.40

自引率

0.00%

发文量

178

审稿时长

8 weeks

期刊介绍： Respirology Case Reports is an open-access online journal dedicated to the publication of original clinical case reports, case series, clinical images and clinical videos in all fields of respiratory medicine. The Journal encourages the international exchange between clinicians and researchers of experiences in diagnosing and treating uncommon diseases or diseases with unusual presentations. All manuscripts are peer-reviewed through a streamlined process that aims at providing a rapid turnaround time from submission to publication.